Inovio Pharmaceuticals
INO
#8871
Rank
C$0.20 B
Marketcap
C$2.97
Share price
-0.69%
Change (1 day)
-48.03%
Change (1 year)

EPS for Inovio Pharmaceuticals (INO)

EPS in 2025 (TTM): C-$3.98

According to Inovio Pharmaceuticals's latest financial reports the company's current EPS (TTM) is C-$3.97. In 2024 the company made an earnings per share (EPS) of C-$5.44 an increase over its 2023 EPS that were of C-$8.39.

EPS history for Inovio Pharmaceuticals from 1999 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C-$3.98-26.88%
2024C-$5.44-35.14%
2023C-$8.39-56.62%
2022C-$19.34-19.54%
2021C-$24.0435.9%
2020C-$17.69-11.57%
2019C-$20.0015.24%
2018C-$17.36-2.78%
2017C-$17.856.93%
2016C-$16.70134.88%
2015C-$7.11-29.51%
2014C-$10.08-57.34%
2013C-$23.64146.55%
2012C-$9.5920.83%
2011C-$7.94-29.41%
2010C-$11.24-48.48%
2009C-$21.8210%
2008C-$19.8411.11%
2007C-$17.85-41.3%
2006C-$30.42-66.91%
2005C-$91.91110.61%
2004C-$43.64-61.63%
2003C-$113.74186.67%
2002C-$39.68
2001N/A-100%
2000C-$31.74-63.64%
1999C-$87.29

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
C$2.37-159.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
C$14.38-462.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
C-$1.72-56.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$10.14-355.56%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
C$10.46-363.67%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
C$4.95-224.86%๐Ÿ‡ฌ๐Ÿ‡ง UK
Gilead Sciences
GILD
C$8.98-326.39%๐Ÿ‡บ๐Ÿ‡ธ USA